118 related articles for article (PubMed ID: 11676284)
21. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.
Fagan AM; Watson M; Parsadanian M; Bales KR; Paul SM; Holtzman DM
Neurobiol Dis; 2002 Apr; 9(3):305-18. PubMed ID: 11950276
[TBL] [Abstract][Full Text] [Related]
22. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
23. Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.
Noy D; Solomonov I; Sinkevich O; Arad T; Kjaer K; Sagi I
J Am Chem Soc; 2008 Jan; 130(4):1376-83. PubMed ID: 18179213
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
25. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
Kirkitadze MD; Kowalska A
Acta Biochim Pol; 2005; 52(2):417-23. PubMed ID: 15933761
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
28. Early-stage inflammation and experimental therapy in transgenic models of the Alzheimer-like amyloid pathology.
Cuello AC; Ferretti MT; Leon WC; Iulita MF; Melis T; Ducatenzeiler A; Bruno MA; Canneva F
Neurodegener Dis; 2010; 7(1-3):96-8. PubMed ID: 20173335
[TBL] [Abstract][Full Text] [Related]
29. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
30. Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers.
Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
Biochemistry; 2005 Jan; 44(1):165-73. PubMed ID: 15628857
[TBL] [Abstract][Full Text] [Related]
31. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
[TBL] [Abstract][Full Text] [Related]
32. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
[TBL] [Abstract][Full Text] [Related]
33. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
34. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
36. Dense-core and diffuse Abeta plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy.
Rak M; Del Bigio MR; Mai S; Westaway D; Gough K
Biopolymers; 2007 Nov; 87(4):207-17. PubMed ID: 17680701
[TBL] [Abstract][Full Text] [Related]
37. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
38. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
39. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model.
Okura Y; Kohyama K; Park IK; Matsumoto Y
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1063-71. PubMed ID: 18957895
[TBL] [Abstract][Full Text] [Related]
40. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]